NASDAQ
Neumora Therapeutics, Inc. Common Stock (NMRA) has a free cash flow growth of 3.20% as of Friday, May 29, 2026. This represents a 549.26% increase compared to its 12-month average of 0.49%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.